TSHA — TAYSHA GENE THERAPIES INC

Ownership history in Point72 (DIFC) Ltd  ·  2 quarters on record

This page tracks every 13F SEC filing in which Point72 (DIFC) Ltd reported a position in TAYSHA GENE THERAPIES INC (TSHA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 REDUCED 4,441 -11,087 -71.4% 0.00% $10K $2.31
2025 Q1 INITIATED 15,528 — — 0.00% $22K $1.39
% of Fund (quarterly)    TSHA price (monthly, adj. close)

Other funds also holding TSHA

As of 2025 Q4 — sorted by position size

B Group, Inc. 7.31% Octagon Capital Advisors LP 3Y 5.92% GordonMD Global Investments LP 5.25% SUPERSTRING CAPITAL MANAGEMENT LP 2.89% Ally Bridge Group (NY) LLC 3Y 2.86% Ally Bridge Group (NY) LLC 3Y 2.62% Vestal Point Capital, LP 2.57% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 1.7% Siren, L.L.C. 1.66% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 1.33%
← Back to Point72 (DIFC) Ltd Holdings